Janux Therapeutics, Inc.
JANX
Revenue
0.00
0.000.00%
-Assets
1.00B
▼-23.20M▼-2.26%
3 Months ChangeLiabilities
44.74M
▼-3.47M▼-7.19%
3 Months ChangeFree Cash Flow
-17.40M
▼-2.36M▼-15.70%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001193125-26-076627
2026-01-22
Form 8-K
ID: 0001193125-26-019520
2025-11-06
Form 10-Q
ID: 0001193125-25-269799
2025-11-06
Form 8-K
ID: 0001193125-25-269518
2025-09-19
Form 8-K
ID: 0001193125-25-209259
2025-08-07
Form 10-Q
ID: 0000950170-25-105069
2025-08-07
Form 8-K
ID: 0000950170-25-105010
2025-06-13
Form 8-K
ID: 0000950170-25-086284
2025-05-08
Form 10-Q
ID: 0000950170-25-067083
2025-05-08
Form 8-K
ID: 0000950170-25-066969